ヒトインスリンの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Human Insulin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8103224)・商品コード:GIR8103224
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月22日
・ページ数:137
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥372,360見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥558,540見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥744,720見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、ヒトインスリンの世界市場について調べ、まとめました。種類別セグメントは、インスリン類似体およびバイオシミラー、ヒトインスリン生物製剤等、用途別セグメントは、短時間作用、中期作用、長時間作用、プレミックスインスリン等に区分しました。ヒトインスリンの世界市場概観、メーカー動向、メーカー別ヒトインスリンシェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・ヒトインスリンの市場概観
・ヒトインスリンのメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・ヒトインスリンのメーカー別販売動向、市場シェア、市場集中度、競争動向
・ヒトインスリンの世界市場規模
・ヒトインスリンの北米市場分析(アメリカ、カナダ、メキシコ等)
・ヒトインスリンのアメリカ市場規模推移
・ヒトインスリンのカナダ市場規模推移
・ヒトインスリンのメキシコ市場規模推移
・ヒトインスリンのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・ヒトインスリンのドイツ市場規模推移
・ヒトインスリンのイギリス市場規模推移
・ヒトインスリンのロシア市場規模推移
・ヒトインスリンのアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・ヒトインスリンの日本市場規模推移
・ヒトインスリンの中国市場規模推移
・ヒトインスリンの韓国市場規模推移
・ヒトインスリンのインド市場規模推移
・ヒトインスリンの東南アジア市場規模推移
・ヒトインスリンの南米市場分析(ブラジル、アルゼンチン等)
・ヒトインスリンの中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・ヒトインスリンの種類別分析/市場規模推移(インスリン類似体およびバイオシミラー、ヒトインスリン生物製剤)
・ヒトインスリンの用途別分析/市場規模推移(短時間作用、中期作用、長時間作用、プレミックスインスリン)
・ヒトインスリンの市場予測(地域別予測、種類別予測、用途別予測)
・ヒトインスリンの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.

Scope of the Report:

This report focuses on the Human Insulin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.

The worldwide market for Human Insulin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

B. Braun

Becton, Dickinson

Biocon

Biodel

ELI Lilly

Julphar

NOVO Nordisk

Sanofi

Wockhardt

Ypsomed

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Insulin Analogs and Biosimilars

Human Insulin Biologics

Market Segment by Applications, can be divided into

Short acting

Intermediate acting

Long acting

Pre-mix Insulin

There are 15 Chapters to deeply display the global Human Insulin market.

Chapter 1, to describe Human Insulin Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Human Insulin, with sales, revenue, and price of Human Insulin, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Insulin, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Human Insulin market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Human Insulin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

【レポートの目次】

Table of Contents

1 Market Overview

1.1 Human Insulin Introduction

1.2 Market Analysis by Type

1.2.1 Insulin Analogs and Biosimilars

1.2.2 Human Insulin Biologics

1.3 Market Analysis by Applications

1.3.1 Short acting

1.3.2 Intermediate acting

1.3.3 Long acting

1.3.4 Pre-mix Insulin

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 B. Braun

2.1.1 Business Overview

2.1.2 Human Insulin Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 B. Braun Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Becton, Dickinson

2.2.1 Business Overview

2.2.2 Human Insulin Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Becton, Dickinson Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Biocon

2.3.1 Business Overview

2.3.2 Human Insulin Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biocon Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Biodel

2.4.1 Business Overview

2.4.2 Human Insulin Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Biodel Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 ELI Lilly

2.5.1 Business Overview

2.5.2 Human Insulin Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 ELI Lilly Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Julphar

2.6.1 Business Overview

2.6.2 Human Insulin Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Julphar Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 NOVO Nordisk

2.7.1 Business Overview

2.7.2 Human Insulin Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 NOVO Nordisk Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Sanofi

2.8.1 Business Overview

2.8.2 Human Insulin Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Sanofi Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Wockhardt

2.9.1 Business Overview

2.9.2 Human Insulin Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Wockhardt Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Ypsomed

2.10.1 Business Overview

2.10.2 Human Insulin Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Ypsomed Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Human Insulin Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Human Insulin Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Human Insulin Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Human Insulin Manufacturer Market Share in 2017

3.3.2 Top 6 Human Insulin Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Human Insulin Market Analysis by Regions

4.1 Global Human Insulin Sales, Revenue and Market Share by Regions

4.1.1 Global Human Insulin Sales and Market Share by Regions (2013-2018)

4.1.2 Global Human Insulin Revenue and Market Share by Regions (2013-2018)

4.2 North America Human Insulin Sales and Growth Rate (2013-2018)

4.3 Europe Human Insulin Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Human Insulin Sales and Growth Rate (2013-2018)

4.5 South America Human Insulin Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Human Insulin Sales and Growth Rate (2013-2018)

5 North America Human Insulin by Countries

5.1 North America Human Insulin Sales, Revenue and Market Share by Countries

5.1.1 North America Human Insulin Sales and Market Share by Countries (2013-2018)

5.1.2 North America Human Insulin Revenue and Market Share by Countries (2013-2018)

5.2 United States Human Insulin Sales and Growth Rate (2013-2018)

5.3 Canada Human Insulin Sales and Growth Rate (2013-2018)

5.4 Mexico Human Insulin Sales and Growth Rate (2013-2018)

6 Europe Human Insulin by Countries

6.1 Europe Human Insulin Sales, Revenue and Market Share by Countries

6.1.1 Europe Human Insulin Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Human Insulin Revenue and Market Share by Countries (2013-2018)

6.2 Germany Human Insulin Sales and Growth Rate (2013-2018)

6.3 UK Human Insulin Sales and Growth Rate (2013-2018)

6.4 France Human Insulin Sales and Growth Rate (2013-2018)

6.5 Russia Human Insulin Sales and Growth Rate (2013-2018)

6.6 Italy Human Insulin Sales and Growth Rate (2013-2018)

7 Asia-Pacific Human Insulin by Countries

7.1 Asia-Pacific Human Insulin Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Human Insulin Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Human Insulin Revenue and Market Share by Countries (2013-2018)

7.2 China Human Insulin Sales and Growth Rate (2013-2018)

7.3 Japan Human Insulin Sales and Growth Rate (2013-2018)

7.4 Korea Human Insulin Sales and Growth Rate (2013-2018)

7.5 India Human Insulin Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Human Insulin Sales and Growth Rate (2013-2018)

8 South America Human Insulin by Countries

8.1 South America Human Insulin Sales, Revenue and Market Share by Countries

8.1.1 South America Human Insulin Sales and Market Share by Countries (2013-2018)

8.1.2 South America Human Insulin Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Human Insulin Sales and Growth Rate (2013-2018)

8.3 Argentina Human Insulin Sales and Growth Rate (2013-2018)

8.4 Colombia Human Insulin Sales and Growth Rate (2013-2018)

9 Middle East and Africa Human Insulin by Countries

9.1 Middle East and Africa Human Insulin Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Human Insulin Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Human Insulin Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Human Insulin Sales and Growth Rate (2013-2018)

9.3 UAE Human Insulin Sales and Growth Rate (2013-2018)

9.4 Egypt Human Insulin Sales and Growth Rate (2013-2018)

9.5 Nigeria Human Insulin Sales and Growth Rate (2013-2018)

9.6 South Africa Human Insulin Sales and Growth Rate (2013-2018)

10 Global Human Insulin Market Segment by Type

10.1 Global Human Insulin Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Human Insulin Sales and Market Share by Type (2013-2018)

10.1.2 Global Human Insulin Revenue and Market Share by Type (2013-2018)

10.2 Insulin Analogs and Biosimilars Sales Growth and Price

10.2.1 Global Insulin Analogs and Biosimilars Sales Growth (2013-2018)

10.2.2 Global Insulin Analogs and Biosimilars Price (2013-2018)

10.3 Human Insulin Biologics Sales Growth and Price

10.3.1 Global Human Insulin Biologics Sales Growth (2013-2018)

10.3.2 Global Human Insulin Biologics Price (2013-2018)

11 Global Human Insulin Market Segment by Application

11.1 Global Human Insulin Sales Market Share by Application (2013-2018)

11.2 Short acting Sales Growth (2013-2018)

11.3 Intermediate acting Sales Growth (2013-2018)

11.4 Long acting Sales Growth (2013-2018)

11.5 Pre-mix Insulin Sales Growth (2013-2018)

12 Human Insulin Market Forecast (2018-2023)

12.1 Global Human Insulin Sales, Revenue and Growth Rate (2018-2023)

12.2 Human Insulin Market Forecast by Regions (2018-2023)

12.2.1 North America Human Insulin Market Forecast (2018-2023)

12.2.2 Europe Human Insulin Market Forecast (2018-2023)

12.2.3 Asia-Pacific Human Insulin Market Forecast (2018-2023)

12.2.4 South America Human Insulin Market Forecast (2018-2023)

12.2.5 Middle East and Africa Human Insulin Market Forecast (2018-2023)

12.3 Human Insulin Market Forecast by Type (2018-2023)

12.3.1 Global Human Insulin Sales Forecast by Type (2018-2023)

12.3.2 Global Human Insulin Market Share Forecast by Type (2018-2023)

12.4 Human Insulin Market Forecast by Application (2018-2023)

12.4.1 Global Human Insulin Sales Forecast by Application (2018-2023)

12.4.2 Global Human Insulin Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures



Figure Human Insulin Picture

Table Product Specifications of Human Insulin

Figure Global Sales Market Share of Human Insulin by Types in 2017

Table Human Insulin Types for Major Manufacturers

Figure Insulin Analogs and Biosimilars Picture

Figure Human Insulin Biologics Picture

Figure Human Insulin Sales Market Share by Applications in 2017

Figure Short acting Picture

Figure Intermediate acting Picture

Figure Long acting Picture

Figure Pre-mix Insulin Picture

Figure United States Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure France Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure UK Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure China Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure India Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Human Insulin Revenue (Value) and Growth Rate (2013-2023)

Table B. Braun Basic Information, Manufacturing Base and Competitors

Table B. Braun Human Insulin Type and Applications

Table B. Braun Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Becton, Dickinson Basic Information, Manufacturing Base and Competitors

Table Becton, Dickinson Human Insulin Type and Applications

Table Becton, Dickinson Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biocon Basic Information, Manufacturing Base and Competitors

Table Biocon Human Insulin Type and Applications

Table Biocon Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biodel Basic Information, Manufacturing Base and Competitors

Table Biodel Human Insulin Type and Applications

Table Biodel Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table ELI Lilly Basic Information, Manufacturing Base and Competitors

Table ELI Lilly Human Insulin Type and Applications

Table ELI Lilly Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Julphar Basic Information, Manufacturing Base and Competitors

Table Julphar Human Insulin Type and Applications

Table Julphar Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table NOVO Nordisk Basic Information, Manufacturing Base and Competitors

Table NOVO Nordisk Human Insulin Type and Applications

Table NOVO Nordisk Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Human Insulin Type and Applications

Table Sanofi Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Wockhardt Basic Information, Manufacturing Base and Competitors

Table Wockhardt Human Insulin Type and Applications

Table Wockhardt Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Ypsomed Basic Information, Manufacturing Base and Competitors

Table Ypsomed Human Insulin Type and Applications

Table Ypsomed Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Human Insulin Sales by Manufacturer (2016-2017)

Figure Global Human Insulin Sales Market Share by Manufacturer in 2016

Figure Global Human Insulin Sales Market Share by Manufacturer in 2017

Table Global Human Insulin Revenue by Manufacturer (2016-2017)

Figure Global Human Insulin Revenue Market Share by Manufacturer in 2016

Figure Global Human Insulin Revenue Market Share by Manufacturer in 2017

Figure Top 3 Human Insulin Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Human Insulin Manufacturer (Revenue) Market Share in 2017

Figure Global Human Insulin Sales and Growth Rate (2013-2018)

Figure Global Human Insulin Revenue and Growth Rate (2013-2018)

Table Global Human Insulin Sales by Regions (2013-2018)

Table Global Human Insulin Sales Market Share by Regions (2013-2018)

Table Global Human Insulin Revenue by Regions (2013-2018)

Figure Global Human Insulin Revenue Market Share by Regions in 2013

Figure Global Human Insulin Revenue Market Share by Regions in 2017

Figure North America Human Insulin Sales and Growth Rate (2013-2018)

Figure Europe Human Insulin Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Human Insulin Sales and Growth Rate (2013-2018)

Figure South America Human Insulin Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Human Insulin Sales and Growth Rate (2013-2018)

Figure North America Human Insulin Revenue and Growth Rate (2013-2018)

Table North America Human Insulin Sales by Countries (2013-2018)

Table North America Human Insulin Sales Market Share by Countries (2013-2018)

Figure North America Human Insulin Sales Market Share by Countries in 2013

Figure North America Human Insulin Sales Market Share by Countries in 2017

Table North America Human Insulin Revenue by Countries (2013-2018)

Table North America Human Insulin Revenue Market Share by Countries (2013-2018)

Figure North America Human Insulin Revenue Market Share by Countries in 2013

Figure North America Human Insulin Revenue Market Share by Countries in 2017

Figure United States Human Insulin Sales and Growth Rate (2013-2018)

Figure Canada Human Insulin Sales and Growth Rate (2013-2018)

Figure Mexico Human Insulin Sales and Growth Rate (2013-2018)

Figure Europe Human Insulin Revenue and Growth Rate (2013-2018)

Table Europe Human Insulin Sales by Countries (2013-2018)

Table Europe Human Insulin Sales Market Share by Countries (2013-2018)

Table Europe Human Insulin Revenue by Countries (2013-2018)

Figure Europe Human Insulin Revenue Market Share by Countries in 2016

Figure Europe Human Insulin Revenue Market Share by Countries in 2017

Figure Germany Human Insulin Sales and Growth Rate (2013-2018)

Figure UK Human Insulin Sales and Growth Rate (2013-2018)

Figure France Human Insulin Sales and Growth Rate (2013-2018)

Figure Russia Human Insulin Sales and Growth Rate (2013-2018)

Figure Italy Human Insulin Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Human Insulin Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Human Insulin Sales by Countries (2013-2018)

Table Asia-Pacific Human Insulin Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Human Insulin Sales Market Share by Countries 2017

Table Asia-Pacific Human Insulin Revenue by Countries (2013-2018)

Figure Asia-Pacific Human Insulin Revenue Market Share by Countries 2017

Figure China Human Insulin Sales and Growth Rate (2013-2018)

Figure Japan Human Insulin Sales and Growth Rate (2013-2018)

Figure Korea Human Insulin Sales and Growth Rate (2013-2018)

Figure India Human Insulin Sales and Growth Rate (2013-2018)

Figure Southeast Asia Human Insulin Sales and Growth Rate (2013-2018)

Figure South America Human Insulin Revenue and Growth Rate (2013-2018)

Table South America Human Insulin Sales by Countries (2013-2018)

Table South America Human Insulin Sales Market Share by Countries (2013-2018)

Figure South America Human Insulin Sales Market Share by Countries in 2017

Table South America Human Insulin Revenue by Countries (2013-2018)

Table South America Human Insulin Revenue Market Share by Countries (2013-2018)

Figure South America Human Insulin Revenue Market Share by Countries in 2017

Figure Brazil Human Insulin Sales and Growth Rate (2013-2018)

Figure Argentina Human Insulin Sales and Growth Rate (2013-2018)

Figure Colombia Human Insulin Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Human Insulin Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Human Insulin Sales by Countries (2013-2018)

Table Middle East and Africa Human Insulin Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Human Insulin Sales Market Share by Countries in 2017

Table Middle East and Africa Human Insulin Revenue by Countries (2013-2018)

Table Middle East and Africa Human Insulin Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Human Insulin Revenue Market Share by Countries in 2013

Figure Middle East and Africa Human Insulin Revenue Market Share by Countries in 2017

Figure Saudi Arabia Human Insulin Sales and Growth Rate (2013-2018)

Figure UAE Human Insulin Sales and Growth Rate (2013-2018)

Figure Egypt Human Insulin Sales and Growth Rate (2013-2018)

Figure Nigeria Human Insulin Sales and Growth Rate (2013-2018)

Figure South Africa Human Insulin Sales and Growth Rate (2013-2018)

Table Global Human Insulin Sales by Type (2013-2018)

Table Global Human Insulin Sales Share by Type (2013-2018)

Table Global Human Insulin Revenue by Type (2013-2018)

Table Global Human Insulin Revenue Share by Type (2013-2018)

Figure Global Insulin Analogs and Biosimilars Sales Growth (2013-2018)

Figure Global Insulin Analogs and Biosimilars Price (2013-2018)

Figure Global Human Insulin Biologics Sales Growth (2013-2018)

Figure Global Human Insulin Biologics Price (2013-2018)

Table Global Human Insulin Sales by Application (2013-2018)

Table Global Human Insulin Sales Share by Application (2013-2018)

Figure Global Intermediate acting Sales Growth (2013-2018)

Figure Global Long acting Sales Growth (2013-2018)

Figure Global Pre-mix Insulin Sales Growth (2013-2018)

Figure Global Human Insulin Sales, Revenue and Growth Rate (2018-2023)

Table Global Human Insulin Sales Forecast by Regions (2018-2023)

Table Global Human Insulin Market Share Forecast by Regions (2018-2023)

Figure North America Sales Human Insulin Market Forecast (2018-2023)

Figure Europe Sales Human Insulin Market Forecast (2018-2023)

Figure Asia-Pacific Sales Human Insulin Market Forecast (2018-2023)

Figure South America Sales Human Insulin Market Forecast (2018-2023)

Figure Middle East and Africa Sales Human Insulin Market Forecast (2018-2023)

Table Global Human Insulin Sales Forecast by Type (2018-2023)

Table Global Human Insulin Market Share Forecast by Type (2018-2023)

Table Global Human Insulin Sales Forecast by Application (2018-2023)

Table Global Human Insulin Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List



【レポートのキーワード】

ヒトインスリン、インスリン類似体およびバイオシミラー、ヒトインスリン生物製剤、短時間作用、中期作用、長時間作用、プレミックスインスリン

★調査レポート[ヒトインスリンの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8103224)販売に関する免責事項を必ずご確認ください。
★調査レポート[ヒトインスリンの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆